Genesis MedTech Completes Enrollment in its United States Early Feasibility Study Utilizing the J-Valve™ Transfemoral System for Patients with Severe Aortic Regurgitation
- Written by PR Newswire
JC Medical reports milestone accomplishment with its TAVR device
BURLINGAME, Calif., Feb. 5, 2024 /PRNewswire/ -- Genesis MedTech, a leading medical device company, today announced the completion of enrollment in its United States Early Feasibility Study (EFS) using its dedicated transcatheter aortic valve replacement (TAVR) system,...














